Richard W. Pascoe
Chief Executive Officer at Zevra Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Zevra Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Zevra Therapeutics Inc. April 25, 202318.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 2023 | Zevra Therapeutics Inc. | Open-market purchase | +10,000 | $4.20 | $42,000 |
| Jan 13, 2023 | Zevra Therapeutics Inc. | Open-market purchase | +9,500 | $5.44 | $51,680 |
Questions about Richard W. Pascoe
What boards is Richard W. Pascoe on?
Richard W. Pascoe sits on the board of Zevra Therapeutics Inc.
Has Richard W. Pascoe been a CEO?
Yes — Richard W. Pascoe was CEO of Zevra Therapeutics Inc. (Until October 2023).
How long has Richard W. Pascoe served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.